See the DrugPatentWatch profile for Fezolinetant
What patent covers fezolinetant 45 mg tablets?
The 45 mg tablet is the marketed oral strength of fezolinetant, but whether a specific patent “covers” the 45 mg tablet depends on the patent’s claims (for example, claims may cover the active ingredient itself, a specific salt/polymorph, manufacturing processes, a formulation, or specific dosing regimens rather than a tablet strength). Patent scope is claim-based, and the same product can be covered by multiple different patent families (active ingredient, composition, and method-of-use), each with different expiration timelines.
To identify the patents relevant to the 45 mg tablets, you typically need to check the product-specific patent listings in the relevant jurisdiction (for example, U.S. Orange Book for drug patents tied to approvals, and analogous national registers elsewhere). Those listings identify each patent number and what it covers, along with expected expiration dates.
How long is fezolinetant’s patent protection (and when do patents expire)?
Patent life generally follows patent term rules (commonly 20 years from the earliest effective filing date, subject to adjustments) but can be extended or affected by exclusivities, patent term adjustments, and possible later-filed continuations. Exact “expiration” for fezolinetant depends on:
- The specific patent(s) listed for the approved product (not just the drug name).
- The earliest priority date claimed by each patent.
- Any patent term adjustments or extensions granted.
- Whether the relevant patents are process/formulation/method-of-use versus composition of matter.
Without the specific patent numbers or a jurisdiction (e.g., U.S. vs. EU), the exact expiry date for “fezolinetant 45 mg tablet patent” can’t be stated reliably from the information provided.
Are there different patents for the drug substance vs. the tablet formulation?
Yes. For many branded oral drugs, patent coverage can come from multiple angles:
- Composition of matter covering the active ingredient (and sometimes specific chemical forms such as salts or polymorphs).
- Formulation/composition patents covering how the drug is made into a tablet.
- Method-of-use patents covering a dosing regimen or therapeutic use.
So a “45 mg tablet” may be covered even if some patents refer to a formulation generally, while others refer to dosing or use. A competitor seeking to market a lower-cost version may need to design around formulation claims and/or avoid infringing method-of-use claims, depending on what is still in force.
Can generic or biosimilar versions enter before patent expiry?
For small-molecule drugs like fezolinetant, the relevant pathway is typically generic approval under “abbreviated” mechanisms where applicable, and launch timing often depends on:
- Patent expiry on the listed patents for the approved product.
- Whether the generic triggers a patent challenge and how litigation is resolved.
- Any regulatory exclusivities that can extend market protection even after patent expiry.
If you tell me the country (U.S., UK, EU, etc.) and whether you mean market-entry timing or the patent expiry date itself, I can outline what to check and how the timelines usually play out.
What should you look up to find the exact patent(s) for the 45 mg tablets?
The most direct way is to use the official product patent list for the approved dosage form/strength in the target jurisdiction. For the U.S., that usually means:
- Locate fezolinetant’s branded listing and then pull the “drug substance,” “drug product,” and “method of use” patents and their expiration dates from the official database.
Key practical detail: the same branded product can have several patents listed, and not all will expire at the same time.
What I need from you to give a precise patent answer
Right now, there isn’t enough information to name specific patent numbers or a specific expiration date for “fezolinetant 45 mg tablet patent.” If you share either:
- the jurisdiction (e.g., United States), and
- the patent numbers you’re looking at, or the reference to the brand product listing you’re using,
I can help interpret what the patent claims likely cover and how to read the expiration timeline.
Sources: None provided in your message.